1. UK review and recommendations on the procurement of starting materials by apheresis for advanced therapy medicinal product (ATMP) manufacture. 2021. available at: https://www.theattcnetwork.co.uk/wp-content/uploads/2021/04/PROCUREMENT-OF-STARTING-MATERIALS-BY-APHERESIS-_070521-v1.0.pdf. [accessed 23 August 2021]
2. Advisory Committee on the Safety of Blood, Tissues and Organs, Donation of starting material for cell-based advanced therapies: a sabto review. 2014. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/326823/Cellular_Therapy.pdf. [accessed 23 August 2021]
3. UK Government. SaBTO microbiological safety guidelines: information on the safety of transplanting human organs, tissues, and cells from the advisory committee on the safety of blood, tissues and organs (SaBTO). 2011. Available at: https://www.gov.uk/government/publications/guidance-on-the-microbiological-safety-of-human-organs-tissues-and-cells-used-in-transplantation. [accessed 23 August 2021]
4. Therapeutic pediatric apheresis;Kim;J Clin Apher,2000
5. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy;Mahadeo;Nat. Rev. Clin. Oncol.,2019